Sterile Packaging: Silicone Septums for Multi-Dose Pharmaceutical Vials.

Sterile Packaging: Silicone Septums for Multi-Dose Pharmaceutical Vials

Problem Statement

Multi-dose pharmaceutical vials require septums that maintain sterility after 100+ needle penetrations while resisting drug interaction and autoclaving (121°C, 15 psi). Standard silicone compounds fail due to:

• High compression set (>30%) causing seal failure after repeated punctures
• Extractable silicone oils contaminating biologics
• Swelling in polar solvents (e.g., DMSO, ethanol-based solutions)

Material Science Analysis

RubberQ’s platinum-cured LSR (Liquid Silicone Rubber) outperforms peroxide-cured silicones and bromobutyl rubber due to:

• Crosslink density: Platinum catalysis creates tighter networks with 40% lower extractables vs. peroxide systems
• Filler selection: High-purity silica (<50 ppm heavy metals) prevents drug adsorption
• Additive package: Non-migrating antistatic agents reduce particle shedding during needle insertion

Technical Specifications

• Shore A Hardness: 50 ±5 (ISO 868)
• Tensile Strength: 8.5 MPa (ASTM D412)
• Elongation at Break: 450% (ASTM D412)
• Compression Set (22 hrs @ 100°C): ≤15% (ASTM D395 Method B)
• Temperature Range: -60°C to 200°C (intermittent)
• ISO 10993-5 Cytotoxicity: Class VI compliant

Parameter	Platinum LSR (RubberQ)	Peroxide-Cured HTV Silicone	Bromobutyl Rubber
Needle Penetration Force (21G, 100 cycles)	1.8 ±0.2 N	2.5 ±0.4 N	3.1 ±0.5 N
Extractables (USP <661>)	≤0.5%	≤1.2%	≤2.8%
Swelling in 70% Ethanol (24 hrs)	+3% volume	+8% volume	+15% volume
Autoclave Cycles Before Failure	≥50	30	10

Standard Compliance

RubberQ’s IATF 16949-certified production ensures:

• Batch traceability of raw materials (ASTM D2000 lineage tracking)
• Statistical process control (SPC) on durometer (±2 Shore A tolerance)
• ISO 3601-1 leak testing on 100% of production units

For custom material compound development or IATF 16949 documentation, consult RubberQ’s engineering department.